https://www.selleckchem.com/pr....oducts/semaxanib-su5
Toxicity and drug resistance caused by chemotherapeutic drugs have become bottlenecks in treating tumors. The delivery of anticancer drugs based on nano-carriers is regarded as an ideal way to solve the aforementioned problems. In this study, a new anti-lymphoma nanodrug CD20 aptamer-RBCm@Ag-MOFs/PFK15 (A-RAMP) is designed and constructed, and it consists of two parts 1. metal-organic frameworks Ag-MOFs (AM) loaded with tumor aerobic glycolysis inhibitor PFK15 (P), forming a core part (AMP); 2. targeted molecule CD20 aptamer (A
Like
Comment
Share
